Angiotensin Converting Enzyme Inhibition and Vascular Hypertrophy in Hypertension
Overview
Pharmacology
Authors
Affiliations
The pathogenesis of hypertension is associated with a remodeling of vascular structure. Follow has postulated that the decreased luminal area and thickened medial layer in hypertensive vessels enhances the vasoconstrictive response to vasoactive agents. It is hypothesized that this increase in vascular reactivity may serve to perpetuate hypertension. A growing body of evidence suggests that autocrine-paracrine vasoactive substances and growth factors modulate vascular structure in hypertension. We speculate that therapeutic interventions that normalize blood pressure as well as reverse the vascular remodeling process may have special clinical value. The role of the paracrine renin-angiotensin system and angiotensin converting enzyme inhibitors in hypertension is discussed in this context.
Dynamics of Vascular Remodeling: An Overview and Bibliography.
Bortman , Losordo J Thromb Thrombolysis. 1996; 3(1):71-86.
PMID: 10608041 DOI: 10.1007/BF00226415.
The renin-angiotensin system and coronary vasomotion.
Ertl G, Hu K, Bauer W, Bauer B Heart. 1996; 76(3 Suppl 3):45-52.
PMID: 8977364 PMC: 484488. DOI: 10.1136/hrt.76.3_suppl_3.45.
Endothelial control of vascular and myocardial function in heart failure.
Paulus W Cardiovasc Drugs Ther. 1994; 8(3):437-46.
PMID: 7947359 DOI: 10.1007/BF00877920.
Ertl G Drugs. 1993; 46(2):209-18.
PMID: 7691512 DOI: 10.2165/00003495-199346020-00001.
Weber H, Taylor D, Molloy C J Clin Invest. 1994; 93(2):788-98.
PMID: 7509348 PMC: 293930. DOI: 10.1172/JCI117033.